Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in regeneron pharmaceuticals, inc. of class action lawsuit and upcoming deadlines - regn

New york, ny / access newswire / january 26, 2025 / pomerantz llp announces that a class action lawsuit has been filed against regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq:regn). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-pomlaw), toll-free, ext.
REGN Ratings Summary
REGN Quant Ranking